Rajesh Kushwaha

Employment

• University of Strasbourg Postdoctoral Researcher
  2025 - Present
• Government of India Prime Minister Research Fellow
  2021 - 2025

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (40)

• Stoichiometric glutathione stops Cu-catalyzed Azide-Alkyne Cycloaddition (CuAAC) reactions with Cu-chelating azides
  Chemical Communications 2026 DOI: 10.1039/d6cc03119f
  +Save
• Red-Light-Triggered In Vitro and In Vivo Photocatalytic Cancer Therapy with Polypyridyl Os(II) Photocatalysts
  Journal of Medicinal Chemistry 2026 DOI: 10.1021/acs.jmedchem.6c00472
  +Save
• Photoactivated antibacterial activity of Fe(iii) complexes via singlet oxygen-mediated bacterial membrane lysis
  Dalton Transactions 2025 DOI: 10.1039/D5DT01300C
  +Save
• Zn(ii)-metallo-photoantibiotics: experimental and computational approach identifying a therapeutic role for antibacterial and antibiofilm applications
  Chemical Communications 2025 DOI: 10.1039/D5CC02340H
  +Save
• Turning the Spotlight Away from PDT: Chemodynamic Dominance of 2-(2-Bromopyridin-4-yl)-1H-imidazo[4,5-f][1,10]phenanthroline Based Ru(II)/Ir(III)/Re(I) Complexes against MDA-MB-231
  JOURNAL OF MEDICINAL CHEMISTRY 2025 DOI: 10.1021/ACS.JMEDCHEM.5C02400
  +Save
• Sonodynamic Therapy
  RESONANCE-JOURNAL OF SCIENCE EDUCATION 2025 DOI: 10.1007/S12045-025-1760-Y
  +Save
• Sonodynamic Cancer Therapy by Mn(I)-tricarbonyl Complexes via Ultrasound-triggered CO Release and ROS Generation
  CHEMISTRY-A EUROPEAN JOURNAL 2025 DOI: 10.1002/CHEM.202403454
  +Save
• Recent advances in Rh(III)-based anticancer complexes
  COORDINATION CHEMISTRY REVIEWS 2025 DOI: 10.1016/J.CCR.2024.216306
  +Save
• Reactive Oxygen Species Inducing Triazolylpyridine-Based Ru(II)/Ir(III) Complexes for Therapeutically Enhanced Triple-Negative Breast Cancer Treatment
  JOURNAL OF MEDICINAL CHEMISTRY 2025 DOI: 10.1021/ACS.JMEDCHEM.4C02089
  +Save
• Intracellular Photocatalytic NADH/NAD(P)H Oxidation for Cancer Drug Development
  JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 2025 DOI: 10.1021/JACS.4C18328
  +Save